Serum autotaxin as a novel prognostic marker in patients with non‐ischaemic dilated cardiomyopathy

MLA

Takashi Araki, et al. “Serum Autotaxin as a Novel Prognostic Marker in Patients with Non‐ischaemic Dilated Cardiomyopathy.” ESC Heart Failure, vol. 9, no. 2, Apr. 2022, pp. 1304–13. EBSCOhost, https://doi.org/10.1002/ehf2.13817.

APA

Takashi Araki, Takahiro Okumura, Hiroaki Hiraiwa, Takashi Mizutani, Yuki Kimura, Shingo Kazama, Naoki Shibata, Hideo Oishi, Tasuku Kuwayama, Toru Kondo, Ryota Morimoto, Mikito Takefuji, & Toyoaki Murohara. (2022). Serum autotaxin as a novel prognostic marker in patients with non‐ischaemic dilated cardiomyopathy. ESC Heart Failure, 9(2), 1304–1313. https://doi.org/10.1002/ehf2.13817

Chicago

Takashi Araki, Takahiro Okumura, Hiroaki Hiraiwa, Takashi Mizutani, Yuki Kimura, Shingo Kazama, Naoki Shibata, et al. 2022. “Serum Autotaxin as a Novel Prognostic Marker in Patients with Non‐ischaemic Dilated Cardiomyopathy.” ESC Heart Failure 9 (2): 1304–13. doi:10.1002/ehf2.13817.